High serum carcinoembryonic antigen concentration in patients with colorectal liver metastases is associated with poor cell-mediated immunity, which is predictive of survival

1997 ◽  
Vol 84 (10) ◽  
pp. 1382-1385 ◽  
Author(s):  
J. King ◽  
J. R. M. Caplehorn ◽  
W. B. Ross ◽  
D. L. Morris
Keyword(s):  
Liver Metastases ◽  
Carcinoembryonic Antigen ◽  
Colorectal Liver Metastases ◽  
High Serum ◽  
Cell Mediated Immunity ◽  
Antigen Concentration ◽  
Serum Carcinoembryonic Antigen

Role of carcinoembryonic antigen as a marker for colorectal liver metastases

2013 ◽  
Vol 70 (2) ◽  
pp. 47-50 ◽  
Author(s):  
C. Jones ◽  
S. A. Badger ◽  
E. Epanomeratikis ◽  
L. D. Mckie ◽  
T. Diamond ◽  
...  
Keyword(s):  
Liver Metastases ◽  
Carcinoembryonic Antigen ◽  
Colorectal Liver Metastases

Bronchogenic cyst with high serum carcinoembryonic antigen

2003 ◽  
Vol 51 (1) ◽  
pp. 34-36 ◽  
Author(s):  
Takahiro Oto ◽  
Akio Ando ◽  
Motoi Aoe ◽  
Hiroshi Date ◽  
Nobuyoshi Shimizu
Keyword(s):  
Carcinoembryonic Antigen ◽  
Bronchogenic Cyst ◽  
High Serum ◽  
Serum Carcinoembryonic Antigen

Treatment of colorectal liver metastasis: Comparison of radiofrequency ablation and hepatic resection.

2012 ◽  
Vol 30 (4_suppl) ◽  
pp. 637-637
Author(s):  
Min Yong Yoon ◽  
Hyung Ook Kim
Keyword(s):  
Overall Survival ◽  
Radiofrequency Ablation ◽  
Liver Metastases ◽  
Hepatic Resection ◽  
Recurrence Rate ◽  
Colorectal Liver Metastases ◽  
Survival Rates ◽  
Disease Stage ◽  
Resection Group ◽  
Serum Carcinoembryonic Antigen

637 Background: Hepatic resection is the mainstay of management for colorectal liver metastases. But, the treatment for colorectal liver metastases requires a multidisciplinary therapeutic strategy. The aim of this study was to compare recurrence and survival rates for patients treated with hepatic resection or radiofrequency ablation (RFA) for colorectal liver metastases. Methods: Between July 2002 and September 2010, 52 patients underwent hepatic resection and 58 underwent RFA for synchronous or metachronous colorectal liver metastases. A retrospective analysis was performed. Patients with extrahepatic metastases were excluded. Results: The two groups had similar mean age, comorbid medical conditions, primary disease stage, and number of tumors. Preoperative median serum carcinoembryonic antigen (CEA) level was significantly higher in the resection group (13.8 ng/mL vs. 3.1 ng/mL; p = 0.001). Median diameter of main tumors was significantly greater in resection group (4.1 cm vs. 2.0 cm; p = 0.002). Recurrence rate after treatment was 46.2% (24/52) in the resection group and 70.7% (41/58) in the RFA group. Marginal recurrence after resection or RFA was observed in 7.6% (4/52) and 46.6% (27/58), respectively (p = 0.003). Median recurrence free survival (28.0 vs. 12.0 months; p = 0.007) and median overall survival (43.0 vs. 26.0 months; p = 0.023) were significantly longer in the resection group. Conclusions: Hepatic resection is the treatment of choice for colorectal liver metastases. RFA for colorectal liver metastases was associated with higher marginal recurrence rate and shorter recurrence free and overall survival.

scholarly journals Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications?

HPB ◽  
2016 ◽  
Vol 18 (12) ◽  
pp. 1000-1009 ◽  
Author(s):  
Kazunari Sasaki ◽  
Georgios A. Margonis ◽  
Nikolaos Andreatos ◽  
Ana Wilson ◽  
Faiz Gani ◽  
...  
Keyword(s):  
Liver Metastases ◽  
Carcinoembryonic Antigen ◽  
Colorectal Liver Metastases ◽  
Prognostic Implications
Sign in / Sign up

Export Citation Format

Share Document